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doi:10.1016/j.fjs.2011.11.005Summary A 69-year-old man, who was formerly fit and well without precipitating risk
factors such as hypertension, suffered a right frontal lobar intracerebral hemorrhage (ICH).
The hematoma was removed, and histopathology showed blood clots with no evidence of
malignancy. Two days after the craniotomy, a new lobar ICH occurred in the right parietal
lobe with subfalcine cerebral herniation. The hematoma was again removed via a decompres-
sive craniectomy. Histopathology of the brain tissue overlying the hematoma demonstrated
cerebral amyloid angiopathy (CAA). Four weeks after this, a recurrent ICH in the right parietal
lobe was noted during a cystoscopic procedure. This time the hematoma was treated conser-
vatively. One year later, another ICH in the left frontal lobe developed following a right
femoral neck fracture. This ICH was again treated conservatively. From this example, we have
learnt that histopathological diagnosis can be very helpful for atypical recurrent intracerebral
hemorrhage. Once the diagnosis of CAA is confirmed, conservative treatment is the rule, and
prompt alleviation of physical or psychological stress could minimize the chance of recurrent
ICH.
Copyright ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved., Renai Road, Da’an District,
net.net (J.-H. Tseng).
ight ª 2012, Taiwan Surgical Asso1. Introduction
Cerebral amyloid angiopathy (CAA) commonly presents as
spontaneous intracerebral hemorrhage (ICH) in individuals
over the age of 60 years without a history of systemic
hypertension. CAA-related hemorrhage (CAAH) is character-
ized by recurrent lobar, cortical or subcortical hemorrhageciation. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 A and B: First episode of ICH, right frontal lobe (arrow). There was no abnormally enhanced lesion demonstrated by
contrast medium within or surrounding the hematoma. Histopathology revealed only blood clots. C and D: Second episode of ICH,
right parietal lobe (star) 2 days after the first ICH. Residual hematoma following evacuation of the right frontal lobar ICH and
subfalcine herniation are also shown. White arrowZ external ventricular drainage.
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a patient with CAA who presented with recurrent CAAH four
times in 1 year.2. Case report
A 69-year-old man without a remarkable medical history
suffered from an acute left-sided weakness and speech
disturbance. He was sent to the emergency department
of our hospital. His initial Glasgow Coma Scale (GCS)
was E3M6V3, his blood pressure was 156/80 mmHg and
left-sided hemiparesis (Medical Research Council (MRC)
grade 3/5 of both upper and lower limbs) and dysphasia
were noted. A computerized tomography (CT) scan with
contrast medium disclosed a right frontal lobar ICH with
no abnormal surrounding enhancement (Figs. 1A and B).
The patient had an associated mass effect and no known
cause for the ICH, so a craniotomy for ICH evacuation was
performed. No abnormal cerebrovascular or tumor-likelesions were found during the operation, and histopa-
thology showed blood clots only. Following the operation,
the patient’s muscle power in his left limbs improved to
a MRC grade 4e5/5 and his GCS improved to E4M6Vt. Two
days later he became drowsy, with a GCS of E1M4Vt. A CT
scan revealed a new cortical and subcortical lobar ICH in
the right parietal lobe with significant subfalcine cerebral
herniation (Figs. 1C and D). Accordingly, a decompressive
craniectomy and hematoma evacuation were performed.
Histopathology of the brain tissue overlying the hema-
toma showed CAA (Fig. 2). His GCS recovered to E4M4V1
and he was transferred to a general ward for further
care.
Four weeks after the second operation, the patient
became lethargic (with a GCS of E2M4V1) and a bulging and
tense craniectomy window was seen 6 hours after
a cystoscopy for a urinary bladder stone and benign pros-
tatic hypertrophy. A repeat CT scan disclosed a recurrent
ICH in the right parietal lobe (Figs. 3A and B). There
was sufficient intracranial pressure control through the
Figure 2 Histopathology of the cerebral cortex overlying the hematoma in the second operation. A: Thick-walled vessels with
amorphous depositions in the vessel wall under hematoxylin and eosin stain (arrow, 100). B: Typical amyloid deposition in media
and adventitia layers of the cortical arteriole under Congo red stain (arrow, 100). C: Deposits of amyloid with apple-green
birefringence under polarized microscopy (arrow, 100).
Recurrent hemorrhage in cerebral amyloid angiopathy 27craniectomy window for a conservative treatment to be
adopted. The patient’s GCS recovered gradually to E4M4V1
and remained stationary in the year that followed, until
a new ICH occurred in the left frontal lobe following a rightFigure 3 A and B: Third episode of ICH, right parietal lobe (arrow
brain was minimal. C and D: Fourth episode of ICH, left frontal subco
formation following three episodes of ICH is shown in the right cerfemoral neck fracture and episodes of seizure (Figs. 3C and
D). Due to the minimal mass effect from the hematoma,
conservative treatment was again adopted and the symp-
toms gradually subsided.), and 4 weeks after the second ICH. Subfalcine herniation of
rtical area (arrow), 1 year after the first episode. Porencephaly
ebral hemisphere.
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Amyloid proteins are improperly folded proteins accumu-
lating intra- and extra-cellularly.1 Several human amyloid
proteins have been identified, and there is specific tissue
affinity for their deposition.2 The deposition of amyloid
protein within leptomeningeal and cortical arteries, arte-
rioles, capillaries and, rarely, veins is defined as CAA, and
the mechanisms of amyloid formation and deposition in
cerebral blood vessels are highly complex. Genetic,
biochemical and physiochemical effects account for the
pathogenesis of CAA. The processes triggering cascades of
secondary events include inflammation, oxidative stress
and cell toxicity, all of which eventually initiate the
development of neurodegeneration, such as stroke and
dementia.3,4
The prevalence of CAA increases with age and the
development of dementia. Postmortem investigations
indicate that CAA occurs in up to 92% of patients with
Alzheimer’s dementia.5 In non-demented people, CAA is
rarely seen before the age of 50 years, but may occur in
one-third of individuals after the age of 60. The prevalence
of CAA increases to more than 50% in people over age 90
years.2 Most patients with CAA manifest with non-specific
vasculopathy-related neurodegeneration, such as impaired
memory and cognition, psychological conditions, ataxia,
extrapyramidal signs, seizures and motor dysfunction. The
most serious presentation is CAAH.1,2,5
CAAH is an important cause of morbidity and mortality in
elderly patients.1 A tentative diagnosis of CAAH is often
based on clinical presentations: lobar, cortical or cortico-
subcortical cerebral hemorrhages; and cerebral hemor-
rhages affecting normotensive individuals over the age of
55 years that are frequently multiple and recurrent.1 The
definitive diagnosis of CAAH, however, relies on histopa-
thology showing pink hyaline thickening of the arteries and
arterioles under hematoxylin-eosin staining, and apple-
green birefringence under polarized light on Congo red
staining.2,5 Brain biopsy is limited by its invasiveness, and is
therefore not practical for screening. Non-invasive methods
have been developed to detect the possibility of CAA.
T2-weighted gradient echo magnetic resonance imaging
highlights the presence of hemosiderin in the foci of
a microhemorrhage. Positron emission tomographic imagingwith the b-amyloid-binding Pittsburgh compound B has
been reported as a potentially reliable technique for
detecting the presence of b-amyloid, and so identifying
CAA in living patients.1 These non-invasive methods are of
limited use, however, in the emergency status of ICH.
One of the hallmarks of CAAH is recurrent hemorrhage.
The mechanism of and factors predisposing to recurrent
hemorrhage are unclear, but stress conditions may be one
of the causes.6 Surgery for CAAH, one of the major physical
stresses, should therefore be reserved for situations
where high intracranial pressure cannot be controlled
with medical treatment. When decompressive surgery is
needed, potential complications (such as bleeding near the
operation site or remote area) should be explained to the
patient and to his or her next-of-kin. Every effort, such as
appropriate sedation, pain relief and blood pressure
control, should be made to minimize potential stress during
invasive procedures or daily care.
In conclusion, although histopathology is the gold stan-
dard in diagnosing CAA, early recognition of CAA based
on clinical and imaging findings is feasible and important.
Once the diagnosis is confirmed or deemed likely, conser-
vative treatment should be attempted until a situation is
reached where decompressive surgery becomes essential.
Minimization of stress during daily care may reduce the
recurrence of CAAH.
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